Home » Media

Media

International Program Spotlights the BRICs at the 2013 BIO International Convention
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
Farmers Increasingly Favor Biotech Crops
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

2012 BIO International Convention Opens Voting April 2nd for the Buzz of BIO
Mar 20 2012
WASHINGTON, DC – (March 20, 2012) – The Biotechnology Industry Organization (BIO) announces voting for the Buzz of BIO will open Monday,...
Registration Open for BIO Livestock Biotech Summit
Mar 15 2012
  To Be Held September 19-21, 2012, in Kansas City, MO   WASHINGTON, D.C. (March 15, 2012) – The Biotechnology Industry Organization (...
BIO’s 9th Annual World Congress Shows Strength of Industrial Biotech and Biofuels in Southeast United States
Mar 15 2012
WASHINGTON, D.C. (March 15, 2012) – Biofuel and renewable chemical company executives along with consumer product companies seeking partnerships in the...
BIO Announces Richard Lobb as Managing Director of the Council for Biotechnology Information
Mar 14 2012
WASHINGTON, D.C. (Mar. 14, 2012) – The Biotechnology Industry Organization (BIO) announced today that Richard Lobb has been hired to serve as...
BIO Hails Senate Passage of PAHPA Reauthorization
Mar 8 2012
Washington, DC (March 8, 2012) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement applauding...
BIO Praises House Passage of the Jumpstart Our Business Startups Act
Mar 8 2012
Washington, DC (March 8, 2012) – The Biotechnology Industry Organization (BIO) applauds the House on the passage of H.R. 3606, the Jumpstart Our...
BIO Announces Additional Plenary Speakers for the 2012 World Congress to Address Advanced Biofuels, Renewable Chemicals and Creation of a Biobased Economy
Mar 8 2012
  WASHINGTON, D.C. (Mar. 8, 2012) – Company executives, scientists and government officials will bring a global perspective as featured...
2012 BIO International Convention Super Sessions Focus on Industry Outlook
Mar 7 2012
WASHINGTON, DC – (March 7, 2012) - The 2012 BIO International Convention will feature six Super Sessions highlighting the state of the industry...
BIO Applauds House Committee Vote to Repeal IPAB
Mar 6 2012
Washington, DC (March 6, 2012) – The Biotechnology Industry Organization (BIO) applauded the House Energy and Commerce Committee’s passage of the...
FAST Act Would Provide Patients with Accelerated Access to Innovative Therapies
Mar 6 2012
Washington, DC (March 6, 2012) –Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement of support for...


Biotechnology News

Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model
March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with Psoriasis
March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says the Committee on Fair Drug Pricing (a.k.a. FAIR)
March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...